General MedicationsORALGeneric
ISRADIPINE
ISRADIPINE
Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview ISRADIPINE is listed in Drugs@FDA under application 201067 (ANDA).
Marketing status: Discontinued Active ingredient ISRADIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 10MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-11-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview ISRADIPINE is listed in Drugs@FDA under application 201067 (ANDA). Marketing status: Discontinued Active ingredient ISRADIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 10MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-11-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.